Literature DB >> 30359977

Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options.

Luca Di Lullo1, Claudio Ronco2, Antonio Granata3,2, Ernesto Paoletti4, Vincenzo Barbera5, Mario Cozzolino6, Maura Ravera4, Maria Fusaro7, Antonio Bellasi8.   

Abstract

Chronic hyperkalemia (HK) is a serious medical condition that often manifests in patients with chronic kidney disease (CKD) and heart failure (HF) leading to poor outcomes and necessitating careful management by cardionephrologists. CKD, HF, diabetes, and renin-angiotensin-aldosterone system inhibitors use is known to induce HK. Current therapeutic options are not optimal, as pointed out by a large number of CKD and HF patients with HK. The following review will focus on the main risk factors for developing HK and also aims to provide a guide for a correct diagnosis and present new approaches to therapy.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Chronic kidney disease; Heart failure; Hyperkalemia; Potassium binder; Renin-angiotensin-aldosterone system inhibitors

Mesh:

Substances:

Year:  2018        PMID: 30359977     DOI: 10.1159/000493395

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  5 in total

1.  The RALES Legacy and Finerenone Use on CKD Patients.

Authors:  José A Moura-Neto; Claudio Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2021-08-06       Impact factor: 10.614

2.  Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo-controlled HARMONIZE-Global study.

Authors:  Faiez Zannad; Bang-Gee Hsu; Yoshitaka Maeda; Sug Kyun Shin; Elena M Vishneva; Martin Rensfeldt; Stefan Eklund; June Zhao
Journal:  ESC Heart Fail       Date:  2020-01-15

Review 3.  Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone.

Authors:  Hiromi Rakugi; Satoru Yamakawa; Kotaro Sugimoto
Journal:  Hypertens Res       Date:  2020-11-20       Impact factor: 3.872

4.  Prevalence, clinical impact and costs of hyperkalaemia: Special focus on heart failure.

Authors:  Aldo P Maggioni; Letizia Dondi; Felicita Andreotti; Silvia Calabria; Massimo Iacoviello; Marco Gorini; Lucio Gonzini; Carlo Piccinni; Giulia Ronconi; Nello Martini
Journal:  Eur J Clin Invest       Date:  2021-03-31       Impact factor: 4.686

Review 5.  Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference.

Authors:  Gregor Lindner; Emmanuel A Burdmann; Catherine M Clase; Brenda R Hemmelgarn; Charles A Herzog; Jolanta Małyszko; Masahiko Nagahama; Roberto Pecoits-Filho; Zubaid Rafique; Patrick Rossignol; Adam J Singer
Journal:  Eur J Emerg Med       Date:  2020-10       Impact factor: 4.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.